Skye Bioscience SKYE
NASDAQ SKYE
$1.63 +0.01 (+0.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Change in Other Operating Liabilities (2018 - 2026)

Updated

Analysis

Skye Bioscience (SKYE) Change in Other Operating Liabilities (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -972.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -112.00 Mn
10 Skye Bioscience 7.90 Mn -80.32 Mn - -2.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.81 Mn
Mar 31, 2026 996,701.00
Dec 31, 2025 244,228.00
Sep 30, 2025 348,657.00
Jun 30, 2025 1.36 Mn
Mar 31, 2025 173,222.00
Dec 31, 2024 -1.50 Mn
Sep 30, 2024 905,122.00
Jun 30, 2024 85,154.00
Mar 31, 2024 66,893.00
Dec 31, 2023 61,082.00
Sep 30, 2023 -558,103.00
Jun 30, 2023 57,019.00
Mar 31, 2023 -225,886.00
Dec 31, 2022 -1.87 Mn
Sep 30, 2022 61,100.00
Jun 30, 2022 -13,517.00
Mar 31, 2022 -4,301.00
Dec 31, 2021 -125,159.00
Sep 30, 2021 -118,313.00
API Access

Skye Bioscience Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=SKYE&period=max&api_key=YOUR_API_KEY